**Exploring Temple’s FDA Legacy, Chinese Biotech Innovation, and Novo Nordisk’s Obesity Data – A BioCentury Podcast** The biopharmaceutical industry is...

**Exploring a Unique Collection Addressing Challenges Through Interdisciplinary Approaches** In an increasingly complex and interconnected world, the challenges we face...

# Understanding Supra-Thermal Ions in Inertial Systems: Key Insights and Mechanisms In the realm of plasma physics and inertial confinement...

# Key Medical Breakthroughs and Innovations of 2024 The year 2024 has proven to be a landmark period for medical...

# Top Six Biotech Companies Driving Innovation in India India has emerged as a global hub for biotechnology, leveraging its...

# Dynamic Transcriptomics Reveals Coordinated Transcriptional Regulation of Artemisinin and Phenylpropanoid Biosynthesis Pathways in *Artemisia annua* Under Cold Stress ##...

# Engineering *Escherichia coli* for Optimized Fermentation Conditions in Whole-Cell Catalytic Synthesis of D-Allulose ## Introduction D-Allulose, also known as...

**Impact of Initial Glucose Levels on Vidal Grape Juice Fermentation Efficiency in Ice Wine Production** Ice wine, a luxurious and...

**Lactoferrin Inhibits Hepatocellular Carcinoma Progression by Targeting INTL1 Receptor and Modulating Apoptosis and Cell Cycle Pathways** Hepatocellular carcinoma (HCC) is...

# Exploring the Role and Impact of Natural Killer Cells [Rebroadcast] Natural Killer (NK) cells are a fascinating and essential...

# Exploring the Role and Impact of Natural Killer Cells The human immune system is a complex and highly coordinated...

**Utilizing Stem Cell Membrane Antigens for Immune System Applications** The field of regenerative medicine and immunotherapy has witnessed remarkable advancements...

**Development of a Fully Automated SIMPLE RPA Microfluidic Chip for In Ovo Sex Determination** The poultry industry is a cornerstone...

**How Biotechnology is Turning Christmas Miracles into Reality** The holiday season is a time of wonder, joy, and the occasional...

**How Biotech Innovations Are Turning Christmas Miracles Into Reality** The holiday season is a time of wonder, joy, and hope—a...

**Exploring CAR T Cells Through a Festive Parody Song on the Nature Podcast** In the ever-evolving world of science communication,...

# CAR T Cells: A Festive Parody Song Celebrated on the *Nature* Podcast In the world of science communication, creativity...

**CAR T Cells: A Festive Parody Song Featured on the Nature Podcast** In the world of science communication, creativity often...

**CAR T Cells Explained: A Festive Parody Song from the Nature Podcast** In the world of cutting-edge medical science, few...

**James Wilson’s GEMMABio Raises $34 Million to Propel Gene Therapy Innovations** In a significant milestone for the field of gene...

**GEMMABio Raises $34 Million Under James Wilson’s Leadership to Propel Gene Therapy Innovations** In a groundbreaking development for the biotechnology...

**FDA Approves Vertex Drug for Treating Cystic Fibrosis: A Breakthrough in Precision Medicine** In a landmark decision that underscores the...

# Optimizing Blood-Brain Barrier Transcytosis: Shorter Linker Enhances TfR-Mediated Transport in Bispecific Antibody RmAb158-scFv8D3 The blood-brain barrier (BBB) is a...

**Key Engineering Factors in Developing Next-Generation Oligonucleotide Therapeutics** Oligonucleotide therapeutics, a rapidly evolving class of drugs, have emerged as a...

**Serum-Free Conditioned Medium Enables Adhesion and Growth of Bovine Myogenic Cells on Uncoated Surfaces** The field of cellular agriculture has...

# Mathematical Modeling of Ligand Inter-Nanocluster Connectivity Using Modularity to Decipher Reversible Stem Cell Regulation Stem cells are the cornerstone...

**Serum-Free Conditioned Culture Medium Enables Adhesion and Growth of Bovine Myogenic Cells on Uncoated Surfaces** The field of cellular agriculture...

**Optimized Linker in Bispecific Antibody Enhances Blood-Brain Barrier Transcytosis via TfR in Vitro** The blood-brain barrier (BBB) is a highly...

“Production, Purification, and Biological Activity Assessment of Recombinant Tilapia Lake Virus Segment 4 Protein for Vaccine Development”

# Production, Purification, and Biological Activity Assessment of Recombinant Tilapia Lake Virus Segment 4 Protein for Vaccine Development

## Introduction

Tilapia Lake Virus (TiLV) is an emerging pathogen that poses a significant threat to global aquaculture, particularly the tilapia industry. Tilapia is one of the most widely farmed fish species, providing a critical source of protein and economic stability for millions of people worldwide. TiLV infections can lead to high mortality rates, devastating fish populations and causing substantial economic losses. Developing an effective vaccine against TiLV is a priority for the aquaculture industry to mitigate these impacts.

One promising approach to vaccine development involves the use of recombinant proteins derived from the virus. Segment 4 of the TiLV genome encodes a putative capsid protein that plays a key role in viral replication and immune recognition. This article explores the production, purification, and biological activity assessment of recombinant TiLV Segment 4 protein as a potential vaccine candidate.

## Production of Recombinant TiLV Segment 4 Protein

### Gene Cloning and Expression
The production of recombinant TiLV Segment 4 protein begins with the identification and cloning of the gene encoding the protein. The TiLV genome is segmented, and Segment 4 has been identified as a key structural protein. The gene is amplified using reverse transcription polymerase chain reaction (RT-PCR) from viral RNA extracted from infected fish tissues. The amplified gene is then cloned into an appropriate expression vector, such as pET or pGEX, which allows for high-level expression in a host system.

Escherichia coli (E. coli) is commonly used as the host organism for recombinant protein production due to its rapid growth, ease of genetic manipulation, and cost-effectiveness. The expression vector is transformed into E. coli cells, and protein expression is induced using an inducer such as isopropyl β-D-1-thiogalactopyranoside (IPTG). The recombinant protein is typically expressed as a fusion protein to facilitate downstream purification.

### Optimization of Expression Conditions
To maximize protein yield and solubility, expression conditions such as temperature, inducer concentration, and duration of induction are optimized. Lower temperatures (e.g., 16–25°C) are often used to improve the solubility of recombinant proteins, as high temperatures can lead to the formation of insoluble inclusion bodies.

## Purification of Recombinant TiLV Segment 4 Protein

### Solubility Assessment and Extraction
Following expression, the recombinant protein is extracted from the host cells. If the protein is expressed in a soluble form, it can be recovered from the cell lysate using centrifugation. If the protein forms inclusion bodies, it must be solubilized using denaturants such as urea or guanidine hydrochloride, followed by refolding to restore its native conformation.

### Affinity Chromatography
Affinity chromatography is a widely used method for purifying recombinant proteins. If the protein is